C9 and colorectal carcinoma: Pathway enrichment analysis of KEGG terms by active subnetworks revealed that complement and coagulation pathways were activated with elevated protein levels (C4B, C5, C1QB, and C9) in CRC patients (Figure 3C, Supplemental Table S4).